NCT05459701CompletedPhase 4
Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)
The Hepato-protective Effect of Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)
Source: ClinicalTrials.gov · Last updated 4 Feb 2025
Brief summary (registry, in English)
The aim of this study is to evaluate the effect of dapagliflozin on liver function of patient with NAFLD and T2DM.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 12 Jul 2022
- Start date
- May 2022
- Primary completion date
- Jun 2024
- Lead sponsor
- Rehab Werida
- NCT number
- NCT05459701
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 50
- From May 2022 to the primary completion date, Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with a history of alcohol, smoking, uncontrolled diabetes.
- Thyroid disorders.
- Cardiac problem.
- Chronic liver and decompensated liver disease in the form of hepatitis B and C.
Lab values
- (HbA1c \> 9.0).
Other
- Pregnancy.
- Lactation.
- Hemochromatosis.
- Renal dysfunction.
Who the study is looking for
- Type 2 diabetes mellitus patients.
- HbA1C \< 8.5.
- Patients were They were having fatty liver changes on abdominal ultrasound and mild to moderate elevation of serum liver enzymes.
- BMI more than 30
Age in the registry: 20 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rehab Hussein Werida Coordinator of this site? Confirm its status | Damanhūr | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.